An in‐depth exploration of the differences in expression of IRF8 and its correlation with immune cells in HCC is of great importance for predicting the clinical prognosis of HCC patients and screening appropriate diagnostic targets and intervention strategies. Here, IRF8 is linked to hepatocellular carcinoma.